本文選題：通便方　切入點：肛腸病術(shù)后津虧腸燥型便秘　出處：《河南中醫(yī)藥大學》2016年碩士論文　論文類型：學位論文

【摘要】：目的:本課題系統(tǒng)的觀察了導師自擬通便方治療肛腸病術(shù)后津虧腸燥型便秘的有效性及安全性,通過與滋陰潤腸口服液做對比,觀察通便方治療肛腸病術(shù)后津虧腸燥型便秘的治療效果,并對其安全性進行評估、分析、評價,最終總結(jié)這個經(jīng)驗方在治療肛腸病術(shù)后津虧腸燥型便秘患者的治療效果及安全性,為在臨床上治療肛腸病術(shù)后津虧腸燥型便秘,提供一個合理、科學、安全的方法。方法:所有資料均來源于河南中醫(yī)藥大學第二附屬醫(yī)院肛腸病區(qū),2015年4月—2016年2月的肛腸病術(shù)后津虧腸燥型便秘患者。將80例符合納入標準的肛腸疾病手術(shù)后屬于津虧腸燥型的便秘住院患者,按照每個患者入院時所生成的住院號,采用隨機數(shù)字表法隨機分為治療組和對照組,每組40例。在常規(guī)治療的基礎(chǔ)上,治療組給予導師自擬方通便方,每日1劑,每劑煎400ml,早晚溫服。對照組給予滋陰潤腸口服液,1支/次,日3次,口服。7天為一個療程,治療兩個療程。觀察治療兩個療程后通便方對肛腸病術(shù)后津虧腸燥型便秘患者在排便間隔時間、排便時間、排便次數(shù)、排便困難程度、排便出血及排便時的疼痛程度在臨床癥狀積分上的變化。結(jié)果:通過spss18.0統(tǒng)計軟件統(tǒng)計、處理、分析之后得出結(jié)論:(1)治療組與對照組的患者在經(jīng)過分別治療后,將兩者總的有效率進行對比,有顯著性的不同,即(P值0.05);(2)治療組與對照組患者在進行分別的治療后,在臨床癥狀上,積分較治療前降低,與治療前相比,都有很大的不同,即(P值0.05)。治療組排便間隔時間、排便時間、排便次數(shù)、排便困難程度、排便出血及排便時的疼痛程度情況比較,都有顯著性的差異,即(P值0.05)。結(jié)論:通便方能有效改善肛腸病術(shù)后津虧腸燥型便秘患者排便間隔時間、排便時間、排便次數(shù)、排便困難程度、排便出血及排便疼痛程度,減輕了患者的痛苦,提高了患者的生活質(zhì)量,且無明顯不良反應及毒副作用,值得臨床推廣應用。
[Abstract]:Objective: to observe the efficacy and safety of tutors' self-designed Tongbian recipe in the treatment of post-anal bowel disease constipation, and to compare it with Ziyin Runchang oral liquid. To observe the therapeutic effect of Tongbian recipe in the treatment of postoperative constipation caused by ataxia and intestinal dryness, and to evaluate its safety, to evaluate, analyze and evaluate the safety of the constipation. Finally, we summarize the effect and safety of this experience prescription in the treatment of patients with post-anal bowel disease, which provides a reasonable and scientific method for the treatment of post-operative constipation. Methods: all data were obtained from the anorectal disease area of the second affiliated hospital of Henan university of traditional Chinese medicine. From April 2015 to February 2016, 80 patients with anal-intestinal dryness constipation after operation of anorectal disease were included. Inpatients with constipation that belong to the type of intestinal dryness after the operation of the disease, According to the hospital number generated by each patient on admission, the treatment group was randomly divided into treatment group (n = 40) and control group (n = 40). The control group was given 1 dose of Ziyin Runchang oral liquid, 3 times a day, and 7 days as a course of treatment. Two courses of treatment. Observe the defecation interval, defecation time, defecation frequency, defecation difficulty degree of the patients with constipation due to defecation after two courses of treatment for anal and intestinal diseases, the defecation interval, the defecation time, the defecation frequency, the defecation difficulty degree, Changes in clinical symptom score of stool bleeding and pain during defecation. Results: spss18.0 statistical software was used to calculate, process, and analyze the clinical symptoms of the patients in the treatment group and the control group, and the results showed that the patients in the treatment group and the control group were treated separately. Comparing the total effective rate of the two groups, there was significant difference, that is, the P value of the treatment group and the control group were 0. 05 and 0. 05% respectively. After the patients in the treatment group and the control group were treated separately, their clinical symptoms were lower than those before the treatment, and there were great differences between the treatment group and the control group before the treatment. There were significant differences in defecation interval, defecation time, defecation frequency, defecation difficulty, stool bleeding and pain in the treatment group. Conclusion: the prescription can effectively improve the defecation interval, defecation time, defecation times, defecation difficulty, defecation bleeding and defecation pain in the patients with constipation due to the deficiency of intestine after operation. The quality of life of the patients was improved, and there were no obvious adverse reactions and side effects, so it is worth popularizing and applying in clinic.
【學位授予單位】：河南中醫(yī)藥大學
【學位級別】：碩士
【學位授予年份】：2016
【分類號】：R266;R256.35

【相似文獻】

相關(guān)期刊論文 前7條

1 劉樹新;;血虛、精虧、津虧的臨床特點和相互聯(lián)系?[J];中醫(yī)函授通訊;1986年05期

2 黃純琪;;津虧血瘀疼痛治驗1例[J];中國民間療法;2007年05期

3 王國瑭;;治陽明驗案四則[J];湖北中醫(yī)雜志;1988年02期

4 郭海英;秋季“干燥”下的隱患[J];中國藥店;2005年10期

5 宋振球;;中、西醫(yī)說病不是一回事[J];健身科學;2014年02期

6 山廣志;晚期肺癌從陰虛論治的觀察與體會[J];安徽中醫(yī)臨床雜志;2002年02期

7 ;[J];;年期

相關(guān)碩士學位論文 前2條

1 劉歡;通便方治療肛腸病術(shù)后津虧腸燥型便秘臨床療效觀察[D];河南中醫(yī)藥大學;2016年

2 吳耀宗;針藥并用治療陰虛津虧型便秘臨床研究[D];河南中醫(yī)學院;2014年

，

本文編號：1643158